Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design-Reference-Cited by-同舟云学术

Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design

Published:2022-10-14 Issue:1 Volume:19 Page:318-332
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Toledo Jon B.¹^ORCID,Abdelnour Carla²,Weil Rimona S.³,Ferreira Daniel⁴,Rodriguez‐Porcel Federico⁵,Pilotto Andrea⁶,Wyman‐Chick Kathryn A.⁷,Grothe Michel J.⁸,Kane Joseph P.M.⁹,Taylor Angela¹⁰,Rongve Arvid¹¹,Scholz Sonja¹²,Leverenz James B.¹³,Boeve Bradley F.¹⁴,Aarsland Dag¹⁵,McKeith Ian G.¹⁶,Lewis Simon¹⁷,Leroi Iracema¹⁸,Taylor John P.¹⁹,

Affiliation:

1. Nantz National Alzheimer Center Stanley H. Appel Department of Neurology Houston Methodist Hospital Houston Texas USA

2. Fundació ACE. Barcelona Alzheimer Treatment and Research Center Universitat Autónoma de Barcelona Barcelona Spain

3. Dementia Research Centre Wellcome Centre for Human Neuroimaging Movement Disorders Consortium National Hospital for Neurology and Neurosurgery University College London London UK

4. Division of Clinical Geriatrics Department of Neurobiology Care Sciences and Society Center for Alzheimer's Research Karolinska Institutet Stockholm Sweden

5. Department of Neurology Medical University of South Carolina Charleston South Carolina USA

6. Department of Clinical and Experimental Sciences University of Brescia Parkinson's Disease Rehabilitation Centre FERB ONLUS‐S Isidoro Hospital Trescore Balneario (BG) Italy

7. HealthPartners Center for Memory and Aging and Struthers Parkinson's Center Saint Paul Minnesota USA

8. Instituto de Biomedicina de Sevilla (IBiS) Unidad de Trastornos del Movimiento Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla Sevilla Spain

9. Centre for Public Health Queen's University Belfast Belfast UK

10. Lewy Body Dementia Association Lilburn Georgia USA

11. Department of Research and Innovation Institute of Clinical Medicine (K1) Haugesund Hospital Norway and The University of Bergen Bergen Norway

12. Department of Neurology National Institute of Neurological Disorders and Stroke Neurodegenerative Diseases Research Unit Johns Hopkins University Medical Center Baltimore Maryland USA

13. Lou Ruvo Center for Brain Health Cleveland Clinic Cleveland Ohio USA

14. Department of Neurology and Center for Sleep Medicine Mayo Clinic Rochester Minnesota USA

15. Department of Old Age Psychiatry Institute of Psychiatry Psychology & Neuroscience King's College London, De Crespigny Park London UK

16. Newcastle University Translational and Clinical Research Institute (NUTCRI Newcastle upon Tyne UK

17. ForeFront Parkinson's Disease Research Clinic School of Medical Sciences Brain and Mind Centre University of Sydney Camperdown New South Wales Australia

18. Global Brain Health Institute Trinity College Dublin Dublin Ireland

19. Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12814

Reference170 articles.

1. Neurodegenerative Diseases Target Large-Scale Human Brain Networks

2. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre

3. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

4. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

5. Diagnosis and management of dementia with Lewy bodies

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era;European Journal of Nuclear Medicine and Molecular Imaging;2024-01-29

2. Lewy body dementia: Overcoming barriers and identifying solutions;Alzheimer's & Dementia;2024-01-24

3. Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks;International Journal of Molecular Sciences;2023-12-29

4. Dementia with Lewy bodies: old and new knowledge – Part 1: clinical aspects and diagnostics;Der Nervenarzt;2023-12-13

5. Clinical effects of Lewy body pathology in cognitively impaired individuals;Nature Medicine;2023-07-18